| Shilpa Satish Sawardekar, MD | |
|
152 Sherlock Dr, Statesville, NC 28625-1916 | |
| (704) 838-8210 | |
| (704) 924-5359 |
| Full Name | Shilpa Satish Sawardekar |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 152 Sherlock Dr, Statesville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134449622 | NPI | - | NPPES |
| Entity Name | Piedmont Healthcare Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912999897 PECOS PAC ID: 9638070683 Enrollment ID: O20040114000339 |
News Archive
Recent outbreaks of COVID-19 have been detected following football events in the United States, and games have the potential to become "superspreader" events.
Text message reminders are a low-cost effective strategy for increasing rates of influenza vaccination. A randomized controlled trial in Western Australia identified patients who were at high risk of serious influenza illness and had a mobile phone number on record in their physician's office.
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
› Verified 6 days ago
| Entity Name | Piedmont Cosmetic Surgery And Dermatology Center, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356440663 PECOS PAC ID: 9638158199 Enrollment ID: O20040717000245 |
News Archive
Recent outbreaks of COVID-19 have been detected following football events in the United States, and games have the potential to become "superspreader" events.
Text message reminders are a low-cost effective strategy for increasing rates of influenza vaccination. A randomized controlled trial in Western Australia identified patients who were at high risk of serious influenza illness and had a mobile phone number on record in their physician's office.
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shilpa Satish Sawardekar, MD Po Box 1845, Statesville, NC 28687-1845 Ph: (704) 873-4277 | Shilpa Satish Sawardekar, MD 152 Sherlock Dr, Statesville, NC 28625-1916 Ph: (704) 838-8210 |
News Archive
Recent outbreaks of COVID-19 have been detected following football events in the United States, and games have the potential to become "superspreader" events.
Text message reminders are a low-cost effective strategy for increasing rates of influenza vaccination. A randomized controlled trial in Western Australia identified patients who were at high risk of serious influenza illness and had a mobile phone number on record in their physician's office.
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
› Verified 6 days ago
Stephen B Scheibner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 152 Sherlock Dr, Statesville, NC 28625 Phone: 704-838-8210 Fax: 704-924-5359 | |
Mr. Frank Leroy Foreman, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 550 Brookdale Dr, Statesville, NC 28677 Phone: 704-873-0545 Fax: 704-873-0546 | |
Dr. Erika Katherine Hill, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 152 Sherlock Dr, Statesville, NC 28625 Phone: 704-838-8210 Fax: 704-924-5359 |